Search

everythinglearnresearchcommunity

for

Search:↓

Public interest in finasteride's sexual side effects has significantly increased, highlighting the need for better patient discussions.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Segmental hair analysis can track testosterone over time but needs adjustments for sex, hair color, and washing frequency.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Early diagnosis and treatment of haemochromatosis are crucial for reversing organ damage and improving fertility.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Low testosterone might be a common cause of hair loss in male dogs.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Improving symptoms of male urinary problems may lower the risk of death.

Low androgen levels reduce nitric oxide production in rat penile cells.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride exposure harms tadpole reproduction and hormone balance.

Finasteride for hair loss doesn't harm erectile function; weight loss and exercise improve it.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Finasteride may cause breast enlargement in some men.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Adiantum capillus-veneris Linn reduced hair loss and improved hair growth in mice with testosterone-induced alopecia.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

The junction of the inner and outer prepuce with good blood flow is best for vascular pedicle flaps.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Leydig cell tumors can cause high testosterone in women and are treated by removing the ovaries.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

Finasteride can cause rare breast growth side effect, with varying recovery after stopping.